Dr. Bruce David Cheson, MD

Dr. Cheson practices at Inova Fairfax Hospital - Unit in Falls Church, Virginia.

Dr. Cheson's NPI, 1992703862, was assigned on July 13, 2005. Dr. Cheson graduated from Tufts University School Of Medicine in 1971. Dr. Cheson holds Maryland license D0035917.

Dr. Cheson's primary practice is Inova Fairfax Hospital - Unit, at 3300 Gallows Rd, Falls Church, VA 22046 in Falls Church City. The practice phone is (703) 698-3659.

Dr. Cheson's primary practice is Inova Fairfax Hospital - Unit in Falls Church, Virginia. Dr. Cheson is also affiliated with Inova Fairfax Hospital. The medical group on file is Zangmeister Cancer Center. Dmand AI also links Dr. Cheson to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cheson practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Cheson's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Cheson is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Cheson's licenses on file in 2 states: Maryland and District of Columbia.

Dmand AI lists chronic leukemia and lymphoma among the conditions Dr. Cheson treats.

CMS data shows 801 Medicare services from Dr. Cheson across 9 procedure codes in 2024, for 66 Medicare patients. Medicare paid $33,732 for them. Every service was in an office.

CMS counts 66 Medicare patients who saw Dr. Cheson in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high cholesterol, and 59% have high blood pressure. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cheson's median patient age at 73, with 61% women.

In 2024, Dr. Cheson wrote 100 Medicare Part D claims for 15 patients. 11% of them were for generic drugs. CMS names the drug for 81 of them, across 3 drugs with 11 or more claims each, at $1,187,102 in total drug cost.

Dmand AI links 199 papers to Dr. Cheson, published from 2006 to 2025. 2016 was the busiest year, with 21. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Leukemia, Lymphocytic, Chronic, B-Cell and Rituximab. Dr. Cheson has published most often in J Clin Oncol. Dr. Cheson's most frequent co-authors are Chaitra Shankar Ujjani, MD, Paul Michael Barr, MD and Nancy Lee Bartlett, MD.

Dmand AI links Dr. Cheson to 7 clinical trials, 2 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, B-Cell and Lymphoma, Non-Hodgkin. Open Payments lists research payments to Dr. Cheson that name 1 trial.

CMS Open Payments shows 37 general payments to Dr. Cheson from 17 drug and device companies from 2024 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Eli Lilly and Company paid the most, $14,740. It also lists 2 research payments totaling $68 in 2024, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Cheson, most recently Henry S. Kaplan Lifetime Achievement Award in 2025.

Dr. Cheson graduated from Tufts University School Of Medicine in 1971.

Dr. Cheson is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and CareFirst BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.